Table 2.
Balanced crystalloids | 0 (0, 0) | 1.32 (−2.76, 5.40) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) |
0.27 (−1.63, 2.18) | Iso-oncotic HA | 0 (0, 0) | – | – | – |
0.73 (−0.65, 2.11) | 0.46 (−1.44, 2.35) | L-HES | 0 (0, 0) | −0.40 (−0.63, −0.16) | – |
0.66 (−1.60, 2.93) | 0.39 (−2.40, 3.18) | −0.06 (−2.32, 2.19) | H-HES | – | – |
0.23 (−1.37, 1.83) | −0.04 (−2.21, 2.13) | −0.50 (−1.76, 0.77) | −0.43 (−2.93, 2.06) | Gelatin | – |
0.36 (−2.06, 2.78) | 0.09 (−2.99, 3.17) | −0.37 (−3.16, 2.42) | −0.30 (−3.62, 3.01) | 0.13 (−2.77, 3.03) | Dextran |
Comparison results between priming fluids should be interpreted from column to row, the priming fluids on the column is the intervention group and the priming fluids on the row is the control group. Result of bold and underline is statistically significant. HA: human albumin; L-HES: hydroxyethyl starch with molecular weight 130k; H-HES: hydroxyethyl starch with molecular weight 200k; –: not available.